{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:16:22Z","timestamp":1793225782518,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Science and Technology Research Foundation of Guangdong Province","award":["No. B2022201"],"award-info":[{"award-number":["No. B2022201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metabolic associated fatty liver disease (MAFLD) is rising in incidence and is an increasingly common cause of cirrhosis and hepatocellular carcinoma (HCC). Alterations in the gut microbiota have been shown to correlate with the development and progression of MAFLD. However, little is known regarding differences in the gut microbiomes of MAFLD patients and healthy cohorts, and subgroups at the abnormal activity of hepatic enzymes in China. In this study, we enrolled 81 MAFLD patients and 25 healthy volunteers. The fecal microbiota was assessed using 16S rRNA gene sequencing and metagenomic sequencing. The results suggested that\n                    <jats:italic>Ruminococcus obeum<\/jats:italic>\n                    and\n                    <jats:italic>Alistipes<\/jats:italic>\n                    were most enriched in healthy individuals when compared with MAFLD patients. Microbe\u2010set Enrichment Analysis (MSEA) results showed\n                    <jats:italic>Dorea<\/jats:italic>\n                    ,\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    and\n                    <jats:italic>Megasphaera<\/jats:italic>\n                    are enriched in MAFLD group. We also found that\n                    <jats:italic>Alistipes<\/jats:italic>\n                    has negatively related to serum glucose (GLU), gamma-glutamyl transferase (GGT), and alanine aminotransferase (ALT). Moreover, the abundance of\n                    <jats:italic>Dorea<\/jats:italic>\n                    was found to be significantly overrepresented in the MAFLD patients and the degree of enrichment increased with the increasing abnormal liver enzyme. An increase in\n                    <jats:italic>Dorea<\/jats:italic>\n                    , combined with decreases in\n                    <jats:italic>Alistipes<\/jats:italic>\n                    appears to be characteristic of MAFLD patients. Further study of microbiota may provide a novel insight into the pathogenesis of MAFLD as well as a novel treatment strategy.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-37163-4","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T05:02:01Z","timestamp":1687237321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Characteristics of gut microbiota in patients with metabolic associated fatty liver disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Chao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangzhuo","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"37163_CR1","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: A multisystem disease. J. Hepatol. 62, S47-64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012 (2015).","journal-title":"J. Hepatol."},{"key":"37163_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","volume":"13","author":"ME Rinella","year":"2016","unstructured":"Rinella, M. E. & Sanyal, A. J. Management of NAFLD: A stage-based approach. Nat. Rev. Gastroenterol. Hepatol. 13, 196\u2013205. https:\/\/doi.org\/10.1038\/nrgastro.2016.3 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"37163_CR3","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.3390\/nu7064995","volume":"7","author":"E Fabbrini","year":"2015","unstructured":"Fabbrini, E. & Magkos, F. Hepatic steatosis as a marker of metabolic dysfunction. Nutrients 7, 4995\u20135019. https:\/\/doi.org\/10.3390\/nu7064995 (2015).","journal-title":"Nutrients"},{"key":"37163_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/17460441.2018.1410135","volume":"13","author":"BK Cole","year":"2018","unstructured":"Cole, B. K., Feaver, R. E., Wamhoff, B. R. & Dash, A. Non-alcoholic fatty liver disease (NAFLD) models in drug discovery. Expert Opin. Drug Discov. 13, 193\u2013205. https:\/\/doi.org\/10.1080\/17460441.2018.1410135 (2018).","journal-title":"Expert Opin. Drug Discov."},{"key":"37163_CR5","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3748\/wjg.v25.i24.3009","volume":"25","author":"JM Mato","year":"2019","unstructured":"Mato, J. M., Alonso, C., Noureddin, M. & Lu, S. C. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World J. Gastroenterol. 25, 3009\u20133020. https:\/\/doi.org\/10.3748\/wjg.v25.i24.3009 (2019).","journal-title":"World J. Gastroenterol."},{"key":"37163_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65, 1038\u20131048. https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012 (2016).","journal-title":"Metabolism"},{"key":"37163_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tim.2017.11.002","volume":"26","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart, A. & Wilmes, P. Human gut microbiome: Function matters. Trends Microbiol. 26, 563\u2013574. https:\/\/doi.org\/10.1016\/j.tim.2017.11.002 (2018).","journal-title":"Trends Microbiol."},{"key":"37163_CR8","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.26355\/eurrev_202002_20213","volume":"24","author":"D Pitocco","year":"2020","unstructured":"Pitocco, D. et al. The role of gut microbiota in mediating obesity and diabetes mellitus. Eur. Rev. Med. Pharmacol. Sci. 24, 1548\u20131562. https:\/\/doi.org\/10.26355\/eurrev_202002_20213 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"37163_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky, J. et al. Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders. Nat. Rev. Gastroenterol. Hepatol. 17, 279\u2013297. https:\/\/doi.org\/10.1038\/s41575-020-0269-9 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"37163_CR10","doi-asserted-by":"publisher","first-page":"660179","DOI":"10.3389\/fimmu.2021.660179","volume":"12","author":"R Martin-Mateos","year":"2021","unstructured":"Martin-Mateos, R. & Albillos, A. The role of the gut-liver axis in metabolic dysfunction-associated fatty liver disease. Front. Immunol. 12, 660179. https:\/\/doi.org\/10.3389\/fimmu.2021.660179 (2021).","journal-title":"Front. Immunol."},{"key":"37163_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/453563","author":"G Son","year":"2010","unstructured":"Son, G., Kremer, M. & Hines, I. N. Contribution of gut bacteria to liver pathobiology. Gastroenterol. Res. Pract. https:\/\/doi.org\/10.1155\/2010\/453563 (2010).","journal-title":"Gastroenterol. Res. Pract."},{"key":"37163_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020270","author":"L Rinaldi","year":"2021","unstructured":"Rinaldi, L. et al. Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review. Antioxidants https:\/\/doi.org\/10.3390\/antiox10020270 (2021).","journal-title":"Antioxidants"},{"key":"37163_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos, S. A., Kountouras, J. & Mantzoros, C. S. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism 92, 82\u201397. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.014 (2019).","journal-title":"Metabolism"},{"key":"37163_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","volume":"48","author":"IA Kirpich","year":"2015","unstructured":"Kirpich, I. A., Marsano, L. S. & McClain, C. J. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin. Biochem. 48, 923\u2013930. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.06.023 (2015).","journal-title":"Clin. Biochem."},{"key":"37163_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MOG.0000000000000349","volume":"33","author":"K Brandl","year":"2017","unstructured":"Brandl, K. & Schnabl, B. Intestinal microbiota and nonalcoholic steatohepatitis. Curr. Opin. Gastroenterol. 33, 128\u2013133. https:\/\/doi.org\/10.1097\/MOG.0000000000000349 (2017).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"37163_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","volume":"16","author":"F Shen","year":"2017","unstructured":"Shen, F. et al. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary Pancreat. Dis. Int. 16, 375\u2013381. https:\/\/doi.org\/10.1016\/S1499-3872(17)60019-5 (2017).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"37163_CR17","doi-asserted-by":"publisher","first-page":"32002","DOI":"10.1038\/srep32002","volume":"6","author":"B Wang","year":"2016","unstructured":"Wang, B. et al. Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease. Sci. Rep. 6, 32002. https:\/\/doi.org\/10.1038\/srep32002 (2016).","journal-title":"Sci. Rep."},{"key":"37163_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","volume":"20","author":"F Li","year":"2021","unstructured":"Li, F., Ye, J., Shao, C. & Zhong, B. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: A systematic review and Meta-analysis. Lipids Health Dis. 20, 22. https:\/\/doi.org\/10.1186\/s12944-021-01440-w (2021).","journal-title":"Lipids Health Dis."},{"key":"37163_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583. https:\/\/doi.org\/10.1038\/nmeth.3869 (2016).","journal-title":"Nat. Methods"},{"key":"37163_CR20","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/ismej.2014.195","volume":"9","author":"AM Eren","year":"2015","unstructured":"Eren, A. M. et al. Minimum entropy decomposition: Unsupervised oligotyping for sensitive partitioning of high-throughput marker gene sequences. ISME J. 9, 968\u2013979. https:\/\/doi.org\/10.1038\/ismej.2014.195 (2015).","journal-title":"ISME J."},{"key":"37163_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu, L. et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH. Hepatology 57, 601\u2013609. https:\/\/doi.org\/10.1002\/hep.26093 (2013).","journal-title":"Hepatology"},{"key":"37163_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/femsec\/fix153","author":"L Mancabelli","year":"2017","unstructured":"Mancabelli, L. et al. Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis. FEMS Microbiol. Ecol. https:\/\/doi.org\/10.1093\/femsec\/fix153 (2017).","journal-title":"FEMS Microbiol. Ecol."},{"key":"37163_CR23","doi-asserted-by":"publisher","first-page":"21466","DOI":"10.1038\/s41598-020-78511-y","volume":"10","author":"Y Kou","year":"2020","unstructured":"Kou, Y., Xu, X., Zhu, Z., Dai, L. & Tan, Y. Microbe-set enrichment analysis facilitates functional interpretation of microbiome profiling data. Sci. Rep. 10, 21466. https:\/\/doi.org\/10.1038\/s41598-020-78511-y (2020).","journal-title":"Sci. Rep."},{"key":"37163_CR24","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41592-018-0176-y","volume":"15","author":"EA Franzosa","year":"2018","unstructured":"Franzosa, E. A. et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat. Methods 15, 962\u2013968. https:\/\/doi.org\/10.1038\/s41592-018-0176-y (2018).","journal-title":"Nat. Methods"},{"key":"37163_CR25","doi-asserted-by":"publisher","first-page":"e1000465","DOI":"10.1371\/journal.pcbi.1000465","volume":"5","author":"Y Ye","year":"2009","unstructured":"Ye, Y. & Doak, T. G. A parsimony approach to biological pathway reconstruction\/inference for genomes and metagenomes. PLoS Comput. Biol. 5, e1000465. https:\/\/doi.org\/10.1371\/journal.pcbi.1000465 (2009).","journal-title":"PLoS Comput. Biol."},{"key":"37163_CR26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jhep.2020.12.016","volume":"74","author":"KI Zheng","year":"2021","unstructured":"Zheng, K. I., Sun, D. Q., Jin, Y., Zhu, P. W. & Zheng, M. H. Clinical utility of the MAFLD definition. J. Hepatol. 74, 989\u2013991. https:\/\/doi.org\/10.1016\/j.jhep.2020.12.016 (2021).","journal-title":"J. Hepatol."},{"key":"37163_CR27","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.dsx.2020.09.026","volume":"14","author":"MS Kuchay","year":"2020","unstructured":"Kuchay, M. S., Choudhary, N. S. & Mishra, S. K. Pathophysiological mechanisms underlying MAFLD. Diabetes Metab. Syndr. 14, 1875\u20131887. https:\/\/doi.org\/10.1016\/j.dsx.2020.09.026 (2020).","journal-title":"Diabetes Metab. Syndr."},{"key":"37163_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020395","author":"I Milosevic","year":"2019","unstructured":"Milosevic, I. et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20020395 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"37163_CR29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.aohep.2019.06.020","volume":"18","author":"L Guohong","year":"2019","unstructured":"Guohong, L., Qingxi, Z. & Hongyun, W. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis. Ann. Hepatol. 18, 796\u2013803. https:\/\/doi.org\/10.1016\/j.aohep.2019.06.020 (2019).","journal-title":"Ann. Hepatol."},{"key":"37163_CR30","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","volume":"76","author":"Z Safari","year":"2019","unstructured":"Safari, Z. & Gerard, P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell. Mol. Life Sci. 76, 1541\u20131558. https:\/\/doi.org\/10.1007\/s00018-019-03011-w (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"37163_CR31","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.4049\/jimmunol.1300016","volume":"190","author":"LA Zenewicz","year":"2013","unstructured":"Zenewicz, L. A. et al. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 190, 5306\u20135312. https:\/\/doi.org\/10.4049\/jimmunol.1300016 (2013).","journal-title":"J. Immunol."},{"key":"37163_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41564-017-0089-z","volume":"3","author":"M Schirmer","year":"2018","unstructured":"Schirmer, M. et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat. Microbiol. 3, 337\u2013346. https:\/\/doi.org\/10.1038\/s41564-017-0089-z (2018).","journal-title":"Nat. Microbiol."},{"key":"37163_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/19490976.2017.1349041","volume":"8","author":"SK Shahi","year":"2017","unstructured":"Shahi, S. K., Freedman, S. N. & Mangalam, A. K. Gut microbiome in multiple sclerosis: The players involved and the roles they play. Gut Microbes 8, 607\u2013615. https:\/\/doi.org\/10.1080\/19490976.2017.1349041 (2017).","journal-title":"Gut Microbes"},{"key":"37163_CR34","doi-asserted-by":"publisher","first-page":"4607491","DOI":"10.1155\/2017\/4607491","volume":"2017","author":"LM Rocha-Ram\u00edrez","year":"2017","unstructured":"Rocha-Ram\u00edrez, L. M. et al. Probiotic lactobacillus strains stimulate the inflammatory response and activate human macrophages. J. Immunol. Res. 2017, 4607491. https:\/\/doi.org\/10.1155\/2017\/4607491 (2017).","journal-title":"J. Immunol. Res."},{"key":"37163_CR35","doi-asserted-by":"publisher","first-page":"51320","DOI":"10.18632\/oncotarget.9710","volume":"7","author":"R Guerrero-Preston","year":"2016","unstructured":"Guerrero-Preston, R. et al. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment. Oncotarget 7, 51320\u201351334. https:\/\/doi.org\/10.18632\/oncotarget.9710 (2016).","journal-title":"Oncotarget"},{"key":"37163_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","volume":"102","author":"SH Lee","year":"2016","unstructured":"Lee, S. H. et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer 102, 89\u201395. https:\/\/doi.org\/10.1016\/j.lungcan.2016.10.016 (2016).","journal-title":"Lung Cancer"},{"key":"37163_CR37","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027\u20131031. https:\/\/doi.org\/10.1038\/nature05414 (2006).","journal-title":"Nature"},{"key":"37163_CR38","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4254\/wjh.v11.i8.619","volume":"11","author":"KT Velazquez","year":"2019","unstructured":"Velazquez, K. T. et al. Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. World J. Hepatol. 11, 619\u2013637. https:\/\/doi.org\/10.4254\/wjh.v11.i8.619 (2019).","journal-title":"World J. Hepatol."},{"key":"37163_CR39","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1210\/jc.2017-02114","volume":"103","author":"F Ottosson","year":"2018","unstructured":"Ottosson, F. et al. Connection between BMI-related plasma metabolite profile and gut microbiota. J. Clin. Endocrinol. Metab. 103, 1491\u20131501. https:\/\/doi.org\/10.1210\/jc.2017-02114 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"37163_CR40","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nm.4358","volume":"23","author":"R Liu","year":"2017","unstructured":"Liu, R. et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat. Med. 23, 859\u2013868. https:\/\/doi.org\/10.1038\/nm.4358 (2017).","journal-title":"Nat. Med."},{"key":"37163_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1152\/physiolgenomics.00114.2017","volume":"50","author":"N Jiao","year":"2018","unstructured":"Jiao, N. et al. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: A meta-analysis. Physiol. Genom. 50, 244\u2013254. https:\/\/doi.org\/10.1152\/physiolgenomics.00114.2017 (2018).","journal-title":"Physiol. Genom."},{"key":"37163_CR42","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1038\/nutd.2015.9","volume":"5","author":"LK Brahe","year":"2015","unstructured":"Brahe, L. K. et al. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr. Diabetes 5, e159. https:\/\/doi.org\/10.1038\/nutd.2015.9 (2015).","journal-title":"Nutr. Diabetes"},{"key":"37163_CR43","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1053\/j.gastro.2011.07.043","volume":"141","author":"M Rajilic-Stojanovic","year":"2011","unstructured":"Rajilic-Stojanovic, M. et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792\u20131801. https:\/\/doi.org\/10.1053\/j.gastro.2011.07.043 (2011).","journal-title":"Gastroenterology"},{"key":"37163_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4161\/gmic.1.3.12360","volume":"1","author":"XJ Shen","year":"2010","unstructured":"Shen, X. J. et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1, 138\u2013147. https:\/\/doi.org\/10.4161\/gmic.1.3.12360 (2010).","journal-title":"Gut Microbes"},{"key":"37163_CR45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73, 202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039 (2020).","journal-title":"J. Hepatol."},{"key":"37163_CR46","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 41, D590-596. https:\/\/doi.org\/10.1093\/nar\/gks1219 (2013).","journal-title":"Nucleic Acids Res."},{"key":"37163_CR47","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560 (2018).","journal-title":"Bioinformatics"},{"key":"37163_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/bioinformatics\/bty648","volume":"35","author":"B Langmead","year":"2019","unstructured":"Langmead, B., Wilks, C., Antonescu, V. & Charles, R. Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics 35, 421\u2013432. https:\/\/doi.org\/10.1093\/bioinformatics\/bty648 (2019).","journal-title":"Bioinformatics"},{"key":"37163_CR49","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/nmeth.3589","volume":"12","author":"DT Truong","year":"2015","unstructured":"Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902\u2013903. https:\/\/doi.org\/10.1038\/nmeth.3589 (2015).","journal-title":"Nat. Methods"},{"key":"37163_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"37163_CR51","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60 (2011).","journal-title":"Genome Biol."},{"key":"37163_CR52","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","volume":"67","author":"R Tang","year":"2018","unstructured":"Tang, R. et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut 67, 534\u2013541. https:\/\/doi.org\/10.1136\/gutjnl-2016-313332 (2018).","journal-title":"Gut"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37163-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T06:14:17Z","timestamp":1687241657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37163-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37163"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-37163-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9988"}}